{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:38:53Z","timestamp":1790948333519,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00932-0","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:57:08Z","timestamp":1746248228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Protective effects of Alamandine against doxorubicin-induced liver injury in rats"],"prefix":"10.1186","volume":"26","author":[{"given":"Ava","family":"Soltani Hekmat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hekmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Ramezanipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Javanmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"932_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7150\/jca.13248","volume":"7","author":"HS Kim","year":"2016","unstructured":"Kim HS, Kim JH, Kim JW, Kim BC. Chemotherapy in elderly patients with gastric Cancer. J Cancer. 2016;7:88\u201394.","journal-title":"J Cancer"},{"key":"932_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/annonc\/mdw271","volume":"27","author":"MD Hellmann","year":"2016","unstructured":"Hellmann MD, Li BT, Chaft JE, Kris MG. Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol. 2016;27:1829\u201335.","journal-title":"Ann Oncol"},{"key":"932_CR3","first-page":"78","volume":"60","author":"A Szu\u0142awska","year":"2006","unstructured":"Szu\u0142awska A, Czyz M. [Molecular mechanisms of anthracyclines action]. Postepy Hig Med Dosw (Online). 2006;60:78\u2013100.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"932_CR4","doi-asserted-by":"publisher","first-page":"153757","DOI":"10.1016\/j.tox.2024.153757","volume":"503","author":"M Chen","year":"2024","unstructured":"Chen M, Yi Y, Chen B, Zhang H, Dong M, Yuan L, Zhou H, Jiang H, Ma Z. Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology. 2024;503:153757.","journal-title":"Toxicology"},{"key":"932_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1248\/bpb.35.796","volume":"35","author":"X Zhao","year":"2012","unstructured":"Zhao X, Zhang J, Tong N, Chen Y, Luo Y. Protective effects of Berberine on doxorubicin-induced hepatotoxicity in mice. Biol Pharm Bull. 2012;35:796\u2013800.","journal-title":"Biol Pharm Bull"},{"key":"932_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/0960327107076885","volume":"26","author":"A Gokcimen","year":"2007","unstructured":"Gokcimen A, Cim A, Tola HT, Bayram D, Kocak A, Ozg\u00fcner F, Ayata A. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity. Hum Exp Toxicol. 2007;26:519\u201325.","journal-title":"Hum Exp Toxicol"},{"key":"932_CR7","doi-asserted-by":"publisher","first-page":"117599","DOI":"10.1016\/j.lfs.2020.117599","volume":"250","author":"PL Prasanna","year":"2020","unstructured":"Prasanna PL, Renu K, Valsala Gopalakrishnan A. New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sci. 2020;250:117599.","journal-title":"Life Sci"},{"key":"932_CR8","first-page":"4718","volume":"27","author":"MA Morsy","year":"2023","unstructured":"Morsy MA, El-Daly M, Kamel BA, Rifaai RA, Abdel-Gaber SA. Pregnenolone protects the liver against doxorubicin-induced cellular injury by anti-inflammatory, antioxidant, and antiapoptotic mechanisms: role of Keap1\/Nrf2\/HO-1 and P-glycoprotein. Eur Rev Med Pharmacol Sci. 2023;27:4718\u201334.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"932_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4161\/oxim.3.6.14416","volume":"3","author":"OA Alshabanah","year":"2010","unstructured":"Alshabanah OA, Hafez MM, Al-Harbi MM, Hassan ZK, Al Rejaie SS, Asiri YA, Sayed-Ahmed MM. Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxid Med Cell Longev. 2010;3:428\u201333.","journal-title":"Oxid Med Cell Longev"},{"key":"932_CR10","doi-asserted-by":"crossref","unstructured":"Wali AF, Rashid S, Rashid SM, Ansari MA, Khan MR, Haq N, Alhareth DY, Ahmad A, Rehman MU. Naringenin regulates Doxorubicin-Induced liver dysfunction: impact on oxidative stress and inflammation. Plants (Basel) 2020, 9.","DOI":"10.3390\/plants9040550"},{"key":"932_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/nu13010041","volume":"13","author":"N Aljobaily","year":"2021","unstructured":"Aljobaily N, Viereckl MJ, Hydock DS, Aljobaily H, Wu T-Y, Busekrus R, Jones B, Alberson J, Han Y. Creatine alleviates Doxorubicin-Induced liver damage by inhibiting liver fibrosis, inflammation, oxidative stress, and cellular senescence. Nutrients. 2021;13:41.","journal-title":"Nutrients"},{"key":"932_CR12","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.tice.2023.102182","volume":"84","author":"M Demir","year":"2023","unstructured":"Demir M, Altinoz E, Koca O, Elbe H, Onal MO, Bicer Y, Karayakali M. Antioxidant and anti-inflammatory potential of Crocin on the doxorubicin mediated hepatotoxicity in Wistar rats. Tissue Cell. 2023;84:102182.","journal-title":"Tissue Cell"},{"key":"932_CR13","first-page":"500","volume":"27","author":"A Soltani Hekmat","year":"2024","unstructured":"Soltani Hekmat A, Amini F, Javanmardi K. Effects of Alamandine on monocrotaline-induced pulmonary hypertension in rats. Iran J Basic Med Sci. 2024;27:500\u20138.","journal-title":"Iran J Basic Med Sci"},{"key":"932_CR14","doi-asserted-by":"crossref","unstructured":"de Carvalho Santuchi M, Dutra MF, Vago JP, Lima KM, Galv\u00e3o I, de Souza-Neto FP, Morais ESM, Oliveira AC, de Oliveira FCB, Gon\u00e7alves R et al. Angiotensin-(1\u20137) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo. Mediators Inflamm 2019, 2019:2401081.","DOI":"10.1155\/2019\/2401081"},{"key":"932_CR15","doi-asserted-by":"crossref","unstructured":"Hrenak J, Paulis L, Simko F. Angiotensin A\/Alamandine\/MrgD axis: another clue to Understanding cardiovascular pathophysiology. Int J Mol Sci 2016, 17.","DOI":"10.3390\/ijms17071098"},{"key":"932_CR16","doi-asserted-by":"publisher","first-page":"C606","DOI":"10.1152\/ajpcell.00399.2021","volume":"324","author":"ICG Jesus","year":"2023","unstructured":"Jesus ICG, Mesquita T, Souza Santos RA, Guatimosim S. An overview of Alamadine\/MrgD signaling and its role in cardiomyocytes. Am J Physiol Cell Physiol. 2023;324:C606\u201313.","journal-title":"Am J Physiol Cell Physiol"},{"key":"932_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fmed.2019.00107","volume":"6","author":"J Schleifenbaum","year":"2019","unstructured":"Schleifenbaum J. Alamandine and its receptor MrgD pair up to join the protective arm of the Renin-Angiotensin system. Front Med (Lausanne). 2019;6:107.","journal-title":"Front Med (Lausanne)"},{"key":"932_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2019.05.008","volume":"47","author":"E Santos-Alves","year":"2019","unstructured":"Santos-Alves E, Rizo-Roca D, Marques-Aleixo I, Coxito P, Martins S, Guimar\u00e3es JT, Oliveira PJ, Torrella JR, Magalh\u00e3es J, Ascens\u00e3o A. Physical exercise positively modulates DOX-induced hepatic oxidative stress, mitochondrial dysfunction and quality control signaling. Mitochondrion. 2019;47:103\u201313.","journal-title":"Mitochondrion"},{"key":"932_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40360-021-00494-x","volume":"22","author":"A Soltani Hekmat","year":"2021","unstructured":"Soltani Hekmat A, Chenari A, Alipanah H, Javanmardi K. Protective effect of Alamandine on doxorubicin\u2013induced nephrotoxicity in rats. BMC Pharmacol Toxicol. 2021;22:31.","journal-title":"BMC Pharmacol Toxicol"},{"key":"932_CR20","doi-asserted-by":"crossref","unstructured":"Musa AE, Shabeeb D, Alhilfi HSQ. Protective effect of melatonin against Radiotherapy-Induced small intestinal oxidative stress: biochemical evaluation. Med (Kaunas) 2019, 55.","DOI":"10.3390\/medicina55060308"},{"key":"932_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1267\/ahc.22-00059","volume":"56","author":"N Aydemir Celep","year":"2023","unstructured":"Aydemir Celep N, Gedikli S. Protective effect of Silymarin on liver in experimental in the Sepsis model of rats. Acta Histochem Cytochem. 2023;56:9\u201319.","journal-title":"Acta Histochem Cytochem"},{"key":"932_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10520295.2019.1647457","volume":"95","author":"I Akta\u015f","year":"2020","unstructured":"Akta\u015f I, \u00d6zmen \u00d6, Tutun H, Yal\u00e7\u0131n A, T\u00fcrk A. Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats. Biotech Histochem. 2020;95:121\u20138.","journal-title":"Biotech Histochem"},{"key":"932_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1734-1140(09)70041-6","volume":"61","author":"R Injac","year":"2009","unstructured":"Injac R, Radic N, Govedarica B, Perse M, Cerar A, Djordjevic A, Strukelj B. Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 through Inhibition of oxidative stress. Pharmacol Rep. 2009;61:335\u201342.","journal-title":"Pharmacol Rep"},{"key":"932_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/CAD.0000000000000299","volume":"27","author":"K Nagai","year":"2016","unstructured":"Nagai K, Fukuno S, Oda A, Konishi H. Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses. Anticancer Drugs. 2016;27:17\u201323.","journal-title":"Anticancer Drugs"},{"key":"932_CR25","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.3390\/molecules16108601","volume":"16","author":"A Ra\u0161kovi\u0107","year":"2011","unstructured":"Ra\u0161kovi\u0107 A, Stilinovi\u0107 N, Kolarovi\u0107 J, Vasovi\u0107 V, Vukmirovi\u0107 S, Mikov M. The protective effects of Silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules. 2011;16:8601\u201313.","journal-title":"Molecules"},{"key":"932_CR26","first-page":"575","volume":"12","author":"R Motamedi","year":"2024","unstructured":"Motamedi R, Aminzadeh S, Khodayar MJ, Khorsandi L, Salehcheh M. Protective effects of Zingerone on oxidative stress in Doxorubicin-Induced rat hepatotoxicity. Rep Biochem Mol Biol. 2024;12:575\u201385.","journal-title":"Rep Biochem Mol Biol"},{"key":"932_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1939-165X.2007.tb00216.x","volume":"36","author":"NJ Fernandez","year":"2007","unstructured":"Fernandez NJ, Kidney BA. Alkaline phosphatase: beyond the liver. Vet Clin Pathol. 2007;36:223\u201333.","journal-title":"Vet Clin Pathol"},{"key":"932_CR28","doi-asserted-by":"publisher","first-page":"e13400","DOI":"10.1111\/apha.13400","volume":"229","author":"AE Hiensch","year":"2020","unstructured":"Hiensch AE, Bolam KA, Mijwel S, Jeneson JAL, Huitema ADR, Kranenburg O, van der Wall E, Rundqvist H, Wengstrom Y, May AM. Doxorubicin-induced skeletal muscle atrophy: elucidating the underlying molecular pathways. Acta Physiol (Oxf). 2020;229:e13400.","journal-title":"Acta Physiol (Oxf)"},{"key":"932_CR29","doi-asserted-by":"publisher","first-page":"e0151548","DOI":"10.1371\/journal.pone.0151548","volume":"11","author":"LA Biondo","year":"2016","unstructured":"Biondo LA, Lima Junior EA, Souza CO, Cruz MM, Cunha RD, Alonso-Vale MI, Oyama LM, Nascimento CM, Pimentel GD, Dos Santos RV, et al. Impact of doxorubicin treatment on the physiological functions of white adipose tissue. PLoS ONE. 2016;11:e0151548.","journal-title":"PLoS ONE"},{"key":"932_CR30","doi-asserted-by":"publisher","first-page":"C1000","DOI":"10.1152\/ajpcell.00116.2021","volume":"321","author":"B Guo","year":"2021","unstructured":"Guo B, Bennet D, Belcher DJ, Kim HG, Nader GA. Chemotherapy agents reduce protein synthesis and ribosomal capacity in myotubes independent of oxidative stress. Am J Physiol Cell Physiol. 2021;321:C1000\u20139.","journal-title":"Am J Physiol Cell Physiol"},{"key":"932_CR31","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0959-8049(00)00134-9","volume":"36","author":"JA Kramer","year":"2000","unstructured":"Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, Bontenbal M, van Pottelsberghe C, Groenvold M, Paridaens R. Randomised trial of Paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. Eur J Cancer. 2000;36:1488\u201397.","journal-title":"Eur J Cancer"},{"key":"932_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2023.04.009","volume":"204","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang Y, Chen T, Lin Y, Gong J, Xu Q, Wang J, Li J, Meng Y, Li Y, Li X. Caveolin-1 depletion attenuates hepatic fibrosis via promoting SQSTM1-mediated PFKL degradation in HSCs. Free Radic Biol Med. 2023;204:95\u2013107.","journal-title":"Free Radic Biol Med"},{"key":"932_CR33","first-page":"453","volume":"57","author":"S Gawe\u0142","year":"2004","unstructured":"Gawe\u0142 S, Wardas M, Niedworok E, Wardas P. [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek. 2004;57:453\u20135.","journal-title":"Wiad Lek"},{"key":"932_CR34","doi-asserted-by":"crossref","unstructured":"Merino de Paz N, Garc\u00eda-Gonz\u00e1lez M, G\u00f3mez-Bernal F, Quevedo-Abeledo JC, de Vera-Gonz\u00e1lez A, L\u00f3pez-Mejias R, Abreu-Gonz\u00e1lez P, Mart\u00edn-Gonz\u00e1lez C, Gonz\u00e1lez-Gay M, Ferraz-Amaro I. Relationship between malondialdehyde serum levels and disease features in a full characterized series of 284 patients with systemic lupus erythematosus. Antioxid (Basel) 2023, 12.","DOI":"10.3390\/antiox12081535"},{"key":"932_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/emm.2006.63","volume":"38","author":"S-Y Kim","year":"2006","unstructured":"Kim S-Y, Kim S-J, Kim B-J, Rah S-Y, Chung SM, Im M-J, Kim U-H. Doxorubicin-induced reactive oxygen species generation and intracellular Ca2\u2009+\u2009increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med. 2006;38:535\u201345.","journal-title":"Exp Mol Med"},{"key":"932_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","volume":"10","author":"AN Linders","year":"2024","unstructured":"Linders AN, Dias IB, L\u00f3pez Fern\u00e1ndez T, Tocchetti CG, Bomer N. Van der Meer P: A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. Npj Aging. 2024;10:9.","journal-title":"Npj Aging"},{"key":"932_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2478\/v10039-012-0063-1","volume":"58","author":"A Pieni\u0105\u017cek","year":"2013","unstructured":"Pieni\u0105\u017cek A, Czepas J, Piasecka-Zelga J, Gwo\u017adzi\u0144ski K, Koceva-Chy\u0142a A. Oxidative stress induced in rat liver by anticancer drugs doxorubicin, Paclitaxel and docetaxel. Adv Med Sci. 2013;58:104\u201311.","journal-title":"Adv Med Sci"},{"key":"932_CR38","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","volume":"20","author":"H Cicho\u017c-Lach","year":"2014","unstructured":"Cicho\u017c-Lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014;20:8082\u201391.","journal-title":"World J Gastroenterol"},{"key":"932_CR39","doi-asserted-by":"crossref","unstructured":"Biswas SK. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid Med Cell Longev 2016, 2016:5698931.","DOI":"10.1155\/2016\/5698931"},{"key":"932_CR40","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/09603271211010896","volume":"40","author":"AS Hekmat","year":"2021","unstructured":"Hekmat AS, Navabi Z, Alipanah H, Javanmardi K. Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol. 2021;40:1781\u201395.","journal-title":"Hum Exp Toxicol"},{"key":"932_CR41","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1253\/circj.CJ-17-1381","volume":"82","author":"BM Park","year":"2018","unstructured":"Park BM, Phuong HTA, Yu L, Kim SH. Alamandine protects the heart against reperfusion injury via the MrgD receptor. Circ J. 2018;82:2584\u201393.","journal-title":"Circ J"},{"key":"932_CR42","doi-asserted-by":"crossref","unstructured":"de Carvalho Santuchi M, Dutra MF, Vago JP, Lima KM, Galv\u00e3o I, de Souza-Neto FP, Morais e Silva M, Oliveira AC, de Oliveira FCB, Gon\u00e7alves R. Angiotensin-(1\u20107) and alamandine promote anti\u2010inflammatory response in macrophages in vitro and in vivo. Mediators of Inflammation 2019, 2019:2401081.","DOI":"10.1155\/2019\/2401081"},{"key":"932_CR43","doi-asserted-by":"publisher","first-page":"C740","DOI":"10.1152\/ajpcell.00153.2019","volume":"318","author":"ICG Jesus","year":"2020","unstructured":"Jesus ICG, Mesquita TRR, Monteiro ALL, Parreira AB, Santos AK, Coelho ELX, Silva MM, Souza LA, Campagnole-Santos MJ, Santos RS. Alamandine enhances cardiomyocyte contractility in hypertensive rats through a nitric oxide-dependent activation of camkii. Am J Physiology-Cell Physiol. 2020;318:C740\u201350.","journal-title":"Am J Physiology-Cell Physiol"},{"key":"932_CR44","doi-asserted-by":"publisher","first-page":"C702","DOI":"10.1152\/ajpcell.00153.2017","volume":"314","author":"S Jesus ICGd, Scalzo","year":"2018","unstructured":"Jesus ICGd, Scalzo S, Alves F, Marques K, Rocha-Resende C, Bader M, Santos RAS, Guatimosim S. Alamandine acts via MrgD to induce AMPK\/NO activation against ANG II hypertrophy in cardiomyocytes. Am J Physiology-Cell Physiol. 2018;314:C702\u201311.","journal-title":"Am J Physiology-Cell Physiol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00932-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:57:13Z","timestamp":1746248233000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00932-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00932-0","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in full compliance with ethical standards and approved by the Ethics Committee of Fasa University of Medical Sciences (Ethical code: IR.FUMS.REC.1400.018). All animal procedures were performed in accordance with the ARRIVE guidelines (\n                      \n                      ) to ensure rigor, reproducibility, and transparency in animal research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work, the authors only used artificially intelligent proofing tools to enhance the lingual experience for the readers. No other generative AI and AI-assisted technology was used in the writing process. After using the tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}